Concepedia

Helen Brady

HB

Statistics

Publications

23

Citations

2.6K

H-Index

19

Active since

1985

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

Saint Louis University

Loma Linda University

University Medical Center

SignalRx Pharmaceuticals (United States)

Helen Brady is an author at Bristol-Myers Squibb (Switzerland) specializing in life sciences, pharmacology, and molecular biology.

Publications per year

1985–2014

23

Publications

23

A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

Paul W. Hollenbach, Aaron Nguyen, Helen Brady et al. · PLoS ONE · 2010 · 357 citations · Full text

, , +16

Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity

Peter Schäfer, Anastasia Parton, Lori Capone et al. · Cellular Signalling · 2014 · 306 citations · Full text

, , +17

A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor

L R Gooding, Lynne W. Elmore, Ann E. Tollefson et al. · Cell · 1988 · 250 citations

, , +11

Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor Cells

Dominique Verhelle, Laura G. Corral, Kevin Wong et al. · Cancer Research · 2007 · 231 citations

, , +17

Targeting of TAK1 by the NF-κB protein Relish regulates the JNK-mediated immune response in <i>Drosophila</i>

Jin Mo Park, Helen Brady, Maria Grazia Ruocco et al. · Genes & Development · 2004 · 199 citations · Full text

, , +17

1–5 of 23